Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s Why

Hypermarcas (OTCMKTS:HYPMY)’s stock price gapped down prior to trading on Wednesday . The stock had previously closed at $4.16, but opened at $3.96. Hypermarcas shares last traded at $4.0185, with a volume of 541 shares traded.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the company. Jefferies Financial Group upgraded Hypermarcas to a “strong-buy” rating in a research report on Monday. Zacks Research raised Hypermarcas to a “hold” rating in a research report on Wednesday, April 29th. One equities research analyst has rated the stock with a Strong Buy rating and one has given a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy”.

Hypermarcas Price Performance

The firm’s 50 day moving average price is $4.18 and its 200-day moving average price is $4.39. The stock has a market cap of $2.83 billion, a P/E ratio of 8.37 and a beta of 0.71.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter. Hypermarcas had a return on equity of 14.08% and a net margin of 19.41%.The business had revenue of $383.13 million for the quarter. On average, analysts expect that Hypermarcas will post 0.53 earnings per share for the current year.

About Hypermarcas

Hypermarcas SA is a Brazil-based consumer health and pharmaceutical company whose shares trade over the counter in the United States under the symbol HYPMY. Founded in the early 2000s and headquartered in Rio de Janeiro, the company operates as a holding group for a broad portfolio of branded products in the healthcare and personal care sectors.

Through its various subsidiaries, Hypermarcas develops, manufactures and markets prescription and over-the-counter medications, alongside personal care, baby care, home care and nutritional supplement products.